$2.4T
Total marketcap
$72.65B
Total volume
BTC 50.51%     ETH 14.99%
Dominance

Indoco Remedies Limited INDOCO.NS Stock

347 INR {{ price }} -1.602154% {{change_pct}}%
COUNTRY
India
Exchange
NSE
Market Cap
31.99B INR
LOW - HIGH [24H]
343.7 - 354.45 INR
VOLUME [24H]
60.96K INR
{{ volume }}
P/E Ratio
31.57
Earnings per share
10.99 INR

Indoco Remedies Limited Price Chart

Indoco Remedies Limited INDOCO.NS Financial and Trading Overview

Indoco Remedies Limited stock price 347 INR
Previous Close 329.3 INR
Open 332.1 INR
Bid 330.55 INR x 0
Ask 330.95 INR x 0
Day's Range 329.9 - 333.5 INR
52 Week Range 306.4 - 423.9 INR
Volume 93.71K INR
Avg. Volume 131.84K INR
Market Cap 31.35B INR
Beta (5Y Monthly) 0.357876
PE Ratio (TTM) 21.476315
EPS (TTM) 10.99 INR
Forward Dividend & Yield 1.5 (0.47%)
Ex-Dividend Date September 14, 2022
1y Target Est 403 INR

INDOCO.NS Valuation Measures

Enterprise Value 32.87B INR
Trailing P/E 21.476315
Forward P/E 13.117321
PEG Ratio (5 yr expected) 0.95
Price/Sales (ttm) 1.8785316
Price/Book (mrq) 2.966831
Enterprise Value/Revenue 1.97
Enterprise Value/EBITDA 11.489

Trading Information

Indoco Remedies Limited Stock Price History

Beta (5Y Monthly) 0.357876
52-Week Change -6.28%
S&P500 52-Week Change 20.43%
52 Week High 423.9 INR
52 Week Low 306.4 INR
50-Day Moving Average 332.4 INR
200-Day Moving Average 353.65 INR

INDOCO.NS Share Statistics

Avg. Volume (3 month) 131.84K INR
Avg. Daily Volume (10-Days) 183.26K INR
Shares Outstanding 92.15M
Float 36.31M
Short Ratio N/A
% Held by Insiders 60.07%
% Held by Institutions 18.45%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.25
Trailing Annual Dividend Yield 0.68%
5 Year Average Dividend Yield 33.00%
Payout Ratio 0.09729999
Last Split Factor 5:1

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 8.52%
Operating Margin (ttm) 12.91%
Gross Margin 68.75%
EBITDA Margin 17.14%

Management Effectiveness

Return on Assets (ttm) 8.56%
Return on Equity (ttm) 14.71%

Income Statement

Revenue (ttm) 16.69B INR
Revenue Per Share (ttm) 181.11 INR
Quarterly Revenue Growth (yoy) 4.70%
Gross Profit (ttm) 11.47B INR
EBITDA 2.86B INR
Net Income Avi to Common (ttm) 1.42B INR
Diluted EPS (ttm) 15.41
Quarterly Earnings Growth (yoy) -36.19%

Balance Sheet

Total Cash (mrq) 143.4M INR
Total Cash Per Share (mrq) 1.56 INR
Total Debt (mrq) 3.33B INR
Total Debt/Equity (mrq) 32.37 INR
Current Ratio (mrq) 1.904
Book Value Per Share (mrq) 111.55

Cash Flow Statement

Operating Cash Flow (ttm) 1.79B INR
Levered Free Cash Flow (ttm) -794630976 INR

Profile of Indoco Remedies Limited

Country India
State N/A
City Mumbai
Address Indoco House
ZIP 400098
Phone 91 22 6287 1000
Website https://www.indoco.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 6000

Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. The company's products portfolio includes respiratory products, such as Karvol Plus, Febrex Plus, Dropizin, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Sensodent-KF, Poviclean, Rexidin, Sensodent-R, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclopam Plus, Cyclomeff, and Nosic; pain/analgesics products that include Lignox A and Lignox ; and ophthal/otologicals products, such as Renolen, Homide, Dexoren – S, Zincoren, Bfloren, Dexoren, Otorex, Mofloren-D, Mofloren – BF, Macuchek, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Coloferrin, Cal Aid, and MCBM DHA; urology products, such as Cital-H and Cital; Cloben G, Noxa, and Scabex for dermatology; ATM, Clygan, Vepan, and Oxipod for anti-infectives; Hemsyl for blood related therapies; MCBM 69 and D-Chiro for gynecological; Aloja and Aloja M for Anti-Diabetics; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Q&A For Indoco Remedies Limited Stock

What is a current INDOCO.NS stock price?

Indoco Remedies Limited INDOCO.NS stock price today per share is 347 INR.

How to purchase Indoco Remedies Limited stock?

You can buy INDOCO.NS shares on the NSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Indoco Remedies Limited?

The stock symbol or ticker of Indoco Remedies Limited is INDOCO.NS.

Which industry does the Indoco Remedies Limited company belong to?

The Indoco Remedies Limited industry is Drug Manufacturers-Specialty & Generic.

How many shares does Indoco Remedies Limited have in circulation?

The max supply of Indoco Remedies Limited shares is 92.18M.

What is Indoco Remedies Limited Price to Earnings Ratio (PE Ratio)?

Indoco Remedies Limited PE Ratio is 31.57416000 now.

What was Indoco Remedies Limited earnings per share over the trailing 12 months (TTM)?

Indoco Remedies Limited EPS is 10.99 INR over the trailing 12 months.

Which sector does the Indoco Remedies Limited company belong to?

The Indoco Remedies Limited sector is Healthcare.